Myriant Withdraws Proposed US$125 Million IPO

摘要

Quincy, Mass.-based bio-based chemical developer Myriant Corp. withdrew its plans to pursue a US$125 million initial public offering (IPO), according to a January 8 filing with the U.S. Securities and Exchange Commission (SEC). The company didn’t cite any specific reasons for the withdrawal of the proposed IPO in the latest SEC filing. Myriant, founded in 2009, originally filed for the proposed IPO in May 2011. The company is focused on developing bio-based chemical alternatives to their incumbent petroleum counterparts, with a focus on succinic acid.